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Immunodiffusion  procedures provide  extremely powerful tools for the reso- 
lution of  complex  antigen-antibody systems.  The  antisera  utilized  in  such 
studies are almost always prepared by intensive immunization so that the anti- 
body is primarily of the 7S class. A review of the literature has not revealed the 
use of 19S antibody for antigenic analysis in immunodiffusion procedures, or a 
comparison of 7S and 19S antibodies for this purpose. 
Preliminary studies demonstrated that sera collected from guinea pigs 7 days 
postinfection (DPI)  with foot-and-mouth disease  virus  (FMDV)  gave  two 
precipitin  bands with  a  purified  FMDV  preparation  in  Ouehterlony  tests 
while sera collected about 30 DPI gave a single band (1). The antibody demon- 
strable in the sera of FMDV-infected guinea pigs between the 4th and 8th DPI 
is almost solely of the 19S class, while that occurring  after about 30 DPI is 
primarily 7S class  1 (2, 3). Similar observations  on the nature of the antibodies 
produced were made with cattle (2, 4) and swine (5) infected with FMDV. 
The present studies were undertaken to obtain additional information on the 
antigenic  characteristics  of FMDV and to compare  19S  antibody-containing 
sera with 7S antibody-containing sera for these analyses. The results obtained 
demonstrated that 19S  antibody could discriminate  between  three antigenic 
variants of FMDV and enzyme-treated virus preparations that could not be 
differentiated by 7S antibody in immunodiffusion analyses. 
Materials and Methods 
Firus.--Foot-and-mouth disease virus, type A, strain  119  (FMDV, A-119), was used  in 
these studies and was grown in cultures of baby hamster kidney ceils (BHK-21, clone 13 of 
MacPherson and Stoker)  (7),  or was obtained from the vesicular fluid from the footpads of 
guinea pigs infected with the virus. The various preparations of FMDV, A-119, studied were 
grown and purified as follows: 
1. Tissue culture high passage virus: V'mas grown and purified as described by Bachrach et aL 
1 Guinea pig antibodies of the 7S class are generally designated 7ST2 and 7ST1 (6). In the 
present study, no attempt was made to investigate these two antibodies individually and the 
activities studied will be attributed to antibodies of the 19S and 7S classes. 
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(8) and Polatnick and Bachrach (9) was provided by the Virus Production Unit of the Plum 
Island Animal Disease Laboratory. This vires had been passaged approximately 150 times in 
primary calf kidney cell cultures and finally grown in BHK-21 cultures for production pur- 
poses.  These purified virus preparations  contained  from  1 to 6  mg of vims/ml and  were 
shown to be homogenous by various physical and  chemical procedures  (8,  10,  11).  These 
preparations are referred to as 140S-Hi-pass  virus. The 140S designation refers to the sedi- 
mentation coeificient (s rate) of FMDV (12). 
2.  Tissue culture  low passage ~iru~: V'Lrus from infectious bovine tongue epithelium was 
passaged seven times in calf kidney cell cultures and then grown in BHK-21 cells. The 140S 
virus particles were concentrated by (NH4)2SO4 precipitation and purified by centrifugation 
into isodense CsC1 (1.43 g/ml) as described previously (13, 14). This preparation is designated 
140S-Lo-pass  virus. 
3. I_,arge and small plague-foxing viruses: Stocks of large and small plaque-forming variants 
of FMDV, A-119, were isolsted from high passage virus  2 and kindly supplied by Dr. J. Martin- 
sen. These viruses were passaged two additional times in calf kidney cell cultures and grown in 
quantity in BHK-21 cultures. The virus in each preparation was purified in the same manner 
as the  140S-Lo-pass  virus. These preparations of small and  large plaque-forming virus are 
referred  to  as  140S-Sm.pl.  and  140S-Lg.pl.  viruses,  respectively.  Plaque  assays  of  these 
purified viruses confirmed the plaque-producing characteristics reported by Martinsen. ~ 
4. C,  ui,  nea pig vesic,  ular fluid ~rus: 
(a) Virus from infectious bovine tongue epithelium was passaged 23-27 times in guinea pigs 
by intradermal inoculation of the footpads. Fluid collected from the vesicles that are produced 
within about 24 hr after inoculation provides an excellent source of virus. Virus was purified 
directly from the vesicular fluids by centrifugation into isodense CsC1. This virus preparation 
is designated  as  140  S-GP virus. 
(b) A guinea pig source of virus from tissue culture high passage virus was prepared by 
inoculating a group of guinea pigs with 140S-Hi-pass  virus. Four passages were required for 
satisfactory adaptation and fluids obtained from the sixth passage were used for the prepara- 
tion of purified virus as just described. This virus preparation is termed 140S-TC-GP. 
The following is presented  to  summarize  the various purified virus preparations  used: 
140S-Hi-pass  virus  --  FMDV, A-119,  passaged  approximately 150 times in calf kidney cell 
cultures  and  grown  for  purification purposes  in  BHK-21  cultures.  140S-Io-pass  vlrus  = 
FMDV,  A-119,  from  bovine  tongue  epithelium passaged  seven  times  in  calf kidney  cell 
cultures and grown in BHK-21 cultures. 140S-Lg.pL  v/rus  --  large plaque-forming FI~IDV, 
A-119, isolated from 140S-Hi-pass  virus and grown in BHK-21 cultures. 140S-Sin.ft. virus = 
small plaque-forming FMDV, A-119, isolated from 140S-Hi-pass  virus and grown in BHK-21 
cultures. 140S-GP ~/rus  =  FMDV, A-119, passaged 23-27 times by guinea pig footpad inocu- 
lation. 140S-TC-GP ~rus  =  FMDV, A-119, of the 140S-Hi-pass  type passaged six times in 
guinea pigs.  140S-b  ~irus preparaJion will be described under Results.  It was isolated from 
140S-Hi-pass  virus, plaque purified in calf kidney cell cultures,  and grown in quantity in 
BHK-21 cultures. It was purified in the same manner as 140S-Lo-pass virus. 
Antlsera.--Guinea pigs were infected by intradermal inoculation of the plantar pads with a 
guinea pig vesicular fluid source of FMDV, A-119.  At various DPI,  the guinea pigs were 
anesthetized with CO~ and blood samples taken by cardiac puncture. Preliminary studies with 
individual sera indicated that blood collected on the same DPI could be pooled. The pooled 
serum was clarified  by high speed eentrifugation, heated for 30 rain at 56°C and stored at 
--20°C.  A  relatively large pool of 7-DPI serum was prepared  for use in the studies to be 
2 Martinsen,  J. Biological characteristics of two plaque size variants of foot-and-mouth 
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presented. The 7-DPI serum did not contain detectable antibody to the virus protein subunit 
(12S) antigen or to the virus infection  associated (VIA)  antigen  (14). 
The term "hyperimmune" is applied to serum obtained from guinea pigs infected in the 
manner just described but after an additional inoculation of guinea pig-adapted  virus given 
10-12  wk after the initial infection. Blood samples were taken  10 days later and  the serum 
collected and stored as just described.  Hyperimmune sera contain antibody to the 140S, 12S, 
and VIA antigenic components (14). 
Antiserum specific for the  140S particles has been described  (15). In brief, this was pre- 
pared by immunization of guinea pigs with inactivated, purified 140S-Hi-pass  virus emulsified 
in incomplete Freund's adjuvant. Blood samples were taken 35 days after a single inoculation 
of the vaccine. The pooled serum was  absorbed  with virus protein-subunit  antigen  (12S) 
to make the serum specific for 140S particles. This serum is termed anti-140S  serum. 
The ultracentrifugation  procedure using a  KBr-NaNO3 gradient for separating  19S  and 
7S classes of antibodies was performed as described previously (3). 
Serological Methods.--The Ouchterlony-type agar gel diffusion preeipitin technique and the 
acridine orange-staining procedure,  as applied to the study of FMDV, have been described 
(13,  14,  16). Immunoelectrophoretic  analyses  were  performed  by  the  general  method  of 
Scheidegger  (17). In the present investigations, the various virus preparations were adjusted 
to a concentration of approximately 0.5 mg/ml for immunodiffusion assays.  The assays used to 
determine the 140S content of the virus preparations were a quantitative complement-fixation 
procedure  (18) and  spectrophotometric examination at a wavelength of 258 m#  (8).  It was 
necessary to dilute the anti-140S  and hyperimmune sera because of their relatively high 7S 
antibody content  and  its rapid  diffusion.  However, the  7-DPI  serum was generally tested 
undiluted because of the relatively low antibody content  and  the slower  diffusion  of the  19S 
antibody. 
Enzyme Reagents.--Trypsin (Nutritional  Biochemicals  Corp.,  Cleveland,  Ohio),  3  )< 
crystallized chymotrypsin  (Worthington  Biochemical Corp.,  Freehold, N.  J.),  diisopropyl- 
fluorophosphate  (DFP)-chymotr:~psin  (Worthington)  and  5  X  crystalline soybean  trypsin 
inhibitor  (Nutritional  Biochemicals)  were  diluted  in  phosphate-buffered  saline  (PBS)  for 
virus treatment  studies. 
EXPERIMENTAL  AND  RESULTS 
General  Findings.--Preliminary  observations  demonstrated  that  a  7-DPI 
guinea  pig  serum  pool  gave  two  precipitin  bands  with  a  140S-Hi-pass  virus 
preparation while anti-140S serum gave only a single band  (Fig. 1) as did hyper- 
immune serum.  For reasons  that will become evident later,  the precipitin band 
closest to the  7-DPI  serum well will be designated as the  140S-b band,  and  the 
one  closest  to  the  antigen  well as  the  140S-ab  band.  The  antigenic  particles 
responsible for these bands will be indicated accordingly. Acridine orange stain- 
ing  ef  such  reactions  demonstrated  that  both  of  the  7-DPI  serum  precipitin 
bands  stained flame red which indicated  the presence of single-stranded  RNA- 
containing antigen  (16). 
Approximately  20  different  140S-Hi-pass  preparations  were  examined  and 
all gave the same reaction.  An attempt  was made to separate  the two possible 
virus components  by ultracentrifugation  on CsC1 gradients,  but  a  single light- 
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finding it may be assumed that the  140S-b and  140S-ab particles have essen- 
tially the same density of 1.43 g/ml previously determined for FMDV (19). 
The  possibility  that  the  double  banding  was  attributable  to  an  aberrant 
7-DPI serum  pool was explored.  Sera from 20  infected  guinea pigs were col- 
lected  7-DPI and  examined individually,  and  all  gave two bands with  140S- 
Hi-pass  preparations.  An  additional  group  of  guinea  pigs  was  infected  and 
blood collected 3, 4, 5, 6, 7, 10, 12, 14, and 17 DPI and individual sera examined. 
None of the individual  sera collected at 3  DPI gave any reaction while all of 
the 4-, 5-, 6-, and 7-DPI sera reacted and gave double bands. At 10 DPI, double 
bands were vaguely evident with sera from five of the  eight remaining guinea 
pigs, but by 12 DPI, no clear evidence of double bands was obtained. With the 
Fio. I. Precipitin lines formed with 140S-Hi-pass  FMDV (Ag) with undiluted  7-day post- 
infection guinea pig serum (7-DPI) and guinea pig anti-140S serum (a-140S) diluted 1/~. 
14- and 17-DPI samples, only a single precipitin band occurred. Thus, the loss 
of the double-banding effect corresponds to the time of appearance of significant 
levels of 7S antibody and the decline of 19S antibody (3). 
To verify the nature of the antibody occurring in the different sera, 7 DPI, 
hyperimmune and anti-140S sera were ultracentrifuged on KBr-NaNOa density 
gradients and the  1.0-ml fractions collected from the tubes examined for anti- 
body activity. The bottom fraction (fraction 1) of the 7-DPI serum contained 
most of the antibody activity and gave two precipitin bands; some activity was 
also evident in  the second  fraction. The  third  fractions  of  the  hyperimnmne 
and anti-140S sera were the most active and gave single bands; weak precipitin 
reactions were also obtained with fractions 2  and  4.  Fraction  1  of  the  7-DPI 
serum and fraction 3 of the hyperimmune and anti-140S sera were examined by 
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rabbit  antiserum  to  guinea pig serum. Tested against  the virus  antigen,  two 
precipitin arcs in the fast-7-globulin region were obtained with fraction 1 of the 
7-DPI serum, and a single band that extended from the slow- to fast--y-globulin 
region with fraction 3 of the hyperimmune and anti-140S sera. With the latter 
two sera, the intensity of the precipitin arcs was much greater in  the slow-3'- 
globulin region,  and was barely evident in  the  fast-~/-globulin  zone. The  re- 
action with rabbit antiserum confirmed that fraction 1 of the 7-DPI serum con- 
tained primarily fast-3,- and a-globulin components, although  traces of other 
FIG. 2. Immunoelectrophoretic assay of ultracentrifugation, fraction 1 of 7-day postinfec- 
tion guinea pig serum (7-DPI) and fraction 3 of anti-140S (a-140S) and hyperimmune (Hyper) 
sera tested against 140S-Hi-pass  FMDV. 
serum proteins were evident. It is clear that the antibody in the 7-DPI serum 
was a  macroglobulin having fast-7-globulin mobility (19S71),  while the  anti- 
body in hyperimmune and anti-140S sera had a lower s rate and electrophoresed 
primarily as 3'2-globulin with trace amounts of 3q-globulin. 
Effect of Trypsin and Chymotrypsin  on 140S-Hi-Pass Virus.--A recent report 
by Wild and Brown (20)  indicated that the infectivity, density, and antigenic 
activity  of  FMDV  were  altered  by  treatment  with  trypsin.  In view  of  the 
relatively extended exposure of virus to cellular enzymes during virus growth, 
the possibility was considered that the two bands observed were due to "nor- 
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pass virus were treated with 100 #g of trypsin or chymotrypsin for 15 min at 
37°C. The untreated and enzyme-treated preparations were then tested against 
7-DPI and anti-140S  sera (Fig. 3). Tested against 7-DPI serum, the usual two 
bands  were  obtained  with  untreated  virus.  Chymotrypsin-treated virus  also 
gave two bands, but neither clearly coalesced with the untreated virus bands. 
Trypsin-treated virus gave a  single band which did not coalesce with either of 
the untreated virus bands, and additional testing demonstrated that it did not 
coalesce  precisely  with  either  cf  the  two  chymotrypsin-treated virus  bands. 
Thus, testing these preparations against 7-DPI serum indicated that a marked 
alteration of antigenic characteristics had occurred upon enzyme treatment. In 
contrast to the reacticns obtained with 7-DPI serum, the anti-140S serum gave 
Fro. 3. Precipitin lines formed with untreated  (U), trypsln-treated (T), and chymotrypsin- 
treated (C) 140S-Hi-pass  FMDV with 7-day postinfection guinea pig serum (a) and anti-140S 
serum (b). 
single  coalescing  bands  indicating  that  no  evident  antigenic  alteration  had 
occurred.  Hyperimmune  serum  reacted  in  the  same  manner.  The  effect  of 
trypsin on virus was inhibited by soybean  trypsin inhibitor and DFP-chymo- 
trypsin had no effect on the virus. 
An alteration in  the surface characteristics of the enzyme-treated virus was 
also demonstrated by immunodectrophoresis examination of these preparations 
(Fig. 4). The virus samples were electrophoresed and patterns developed with 
7-DPI and anti-140S  sera. Untreated virus remained essentially at the origin, 
chymotrypsin treatment increased the mobility somewhat, while trypsin treat- 
ment caused  a  marked  increase  in  mobility.  Reactions  obtained  with  7-DPI 
serum were weak, but two bands were evident with both untreated and chymo- 
trypsin-treated virus although they are not readily seen in the figure presented. 
The increased mobility of chymotrypsin-treated virus agreed with the findings 
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treated virus. However, reexamination of the effect of freshly prepared trypsin 
on virus confirmed the results reported here? 
Precipitin  reactions  obtained  with  untreated,  trypsin-  and  chymotrypsin- 
treated virus, and 7-DPI serum were stained with acridine orange, and all of the 
bands  took up  the  stain  to  give red  fluorescence.  Therefore,  the  bands  were 
produced by RNA-containing antigens. The information sought in these experi- 
ments was not obtained; however,  the  results of experiments to be presented 
demonstrated  that  the  double bands  obtained with  140S-Hi-pass virus  could 
not be attributed  to enzymatic alteration of the virus particles. 
FIG. 4. Immunoelectrophoresis  of FMDV, A-119, that was untreated  (U), chymotrypsin- 
treated  (C), and trypsin-treated  (T), tested against 7-day postinfection serum (7-DPI) and 
specific anti-140S serum (a-140S) from guinea pigs. 
In  general,  these  observations  indicated  that  modifications  of  the  protein 
coat of FMDV could readily be detected with guinea pig antibody of the 19S 
class, while antibodies of the 7S class were unable to do so. 
Absorption Studies and Purification of 140S-b Particles.--The fact that double 
bands occurred with 7-DPI serum and 140S-Hi-pass virus indicated that if the 
reaction was actually attributable to two antigenic particles,  there would be a 
disproportion  either  in  the  amount  of  each  or  in  the  amount  of  antibodies 
directed against them or both.  Therefore, an absorption  experiment was per- 
formed to eliminate the possibility that the reaction was due to an artifact such 
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as  the Liesegang's phenomenon,  to provide some information on the possible 
preparation  of  specific  antigen  or  antiserum  reagents,  and  to  determine  the 
effect of absorption on the neutralizing activity of the serum. 
To 1.0-ml amounts of 7-DPI serum was added 25, 50,  100, 200, 400, and 800 
#g of 140S-Hi-pass virus in a volume of 0.25 ml. Serum receiving buffer was also 
included as a control. The mixtures were incubated 1 hr at 37°C and then placed 
at 4°C for 4 days. The mixtures were shaken frequently during this incubation 
period. They were finally centrifuged for 1 hr at 2000  rpm in the cold and the 
supernatant fluids collected.  The supernatant fluids were tested for antibody 
Fro. 5. Precipitin activity of 7-day postinfection guinea pig serum (7-DPI) absorbed with 
varying amounts of purified FMDV, A-119, tissue culture-high passage virus (140S-Hi-pass). 
The serum was absorbed with from 25 to 800 #g of 140S-Hi-pass  virus/ml of serum, and the 
numbers in the figure indicate the dosage used. The absorbed serum was tested against 500 
#g/ml of 140S-Hi-pass  virus (a). Unabsorbed 7-DPI serum (U) and hyperimmune serum (H) 
were included for control purposes. The preeipitin bands attributed  to 140S-ab and  140S-b 
particles are indicated. 
activity  by  agar  gel  analysis  against  140S-Hi-pass  virus  (Fig.  5),  and  then 
treated with 0.05 %  acetylethylenimine  (AEI)  (21)  for  24 hr  at  37°C  to  in- 
activate any residual viable virus. The virus-inactivating activity of the AEI 
was  then  neutralized  by  adding  sodium  thiosulfate  (21).  The  AEI-treated 
supernates were tested for virus-neutralizing activity in suckling mice (Table I). 
Two precipitin bands were still obtained with 7-DPI serum treated with 25 
and 50/zg of virus, butwith 100 or 200 #g amounts, the 140S-b band was elimi- 
nated.  With 400 and 800/~g of virus, the  140S-b  component  was in excess as 
evidenced by the precipitin band occurring between the control 7-DPI serum 
wells and these high-dose antigen-serum wells, and the coalescence of this band 
with  the  140S-b  band.  The  antibody  responsible for  the  140S-ab  band  was 
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/~g of virus. Thus, serum absorbed with 400/~g of virus contained free 140S-b 
particles, but also antibody capable of reacting with  140S-ab particles. These 
observations  clearly  indicated  that  two  different  antigenic  components  oc- 
curred in 140S-Hi-pass virus preparations, and that antibodies of two different 
specificities were present in 7-DPI serum. 
With respect to the neutralizing  activity of the absorbed serum (Table I), 
the addition of 200 #g of virus abolished the neutralizing activity but not its 
ability to form a precipitin band with 140S-ab particles (Fig. 5). This suggests 
that the residual  antibody reacting with  140S-ab particles combines with  an 
antigenic determinant that is not critical with respect to virus neutralization. 
TABLE I 
Neutralizing and Precipitating Aetivity of Supernatant Fluids of 7-Day Postinfection Guinea Pig 
Serum Absorbed with Varying Amounts  of Purified, Tissue  Culture-High Passage 
Foot-and-Mouth Disease Virus  (140S-tti-Pass) 
Virus used* for absorption 
per ml serum 
~g 
0 
25 
50 
100 
200 
400 
800 
PD~o~ 
2.22 
1.52 
1.35 
0.91 
<0.3 
<0.3 
<0.3 
Precipitating  activity vs. 
140S-ab 
+ 
+ 
+ 
+ 
+ 
4- 
140S-b 
+ 
+ 
+ 
* Serum and virus were combined and incubated for 1 hr at 37°C followed by 4  days at 
4°C. The supernatant  fluids were collected by centrifugation and treated  with 0.05% acetyl- 
ethylenimine to inactivate any residual viable virus. 
Logl0 of the reciprocal of the serum dilution protecting 5 of 10 suckling mice against 100 
I~50 of virus. 
Absorption  experiments such  as  this  demonstrated  that  7-DPI serum  ab- 
sorbed with 150/zg of 140S-Hi-pass virus per milliliter of serum would  provide 
an antiserum reagent specific for 140S-ab particles  (anti-140S-ab).  These ex- 
periments also  suggested  a  method for purifying  140S-b  particles;  therefore, 
experiments  to  prepare  specific  anti-140S-ab  serum  and  to  purify  140S-b 
particles were carried out. 10 ml of 7-DPI serum was mixed with 1.5 mg of 140S- 
Hi-pass virus (150 #g virus/ml serum)  and incubated with occasional mixing 
for 5 days at 4°C. The mixture was centrifuged at 4°C for 1 hr at 16,000  rpm 
and the supernatant fluid collected.  Agar gel precipitin analysis  demonstrated 
that this absorbed serum reacted only with 140S-ab particles (Fig. 7 b); it was 
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was then combined with additional  140S-Hi-pass virus using 350 #g of virus per 
milliliter  of absorbed  serum.  This  dose  of virus  was selected  so  that  a  slight 
excess  of antibody reactive with  140S-ab  particles  would occur in  the  super- 
natant fluid. This mixture was considered to consist of 140S-ab particles tom- 
FIG. 6. Precipitin  reactions of guinea pig  (a)  7-day postinfection serum  (undiluted);  (b) 
anti-140S serum (diluted 1/~); and (c) hyperimmune serum (diluted 1/~) with FMDV, A-119, 
preparations.  (1) 140S-Hi-passvirus; (2) 140S-Lo-passvirus; (3) 140S-b  virus; (4) 140S-TC-GP 
virus; and (5) 140S-GP virus. All virus preparations were at approximately 500 #g/ml. 
plexed with antibody (precipitate),  a small amount of free antibody to 140S-ab 
particles,  and free 140S-b particles.  After 4 days of incubation at 4°C,  the pre- 
cipitate was removed by high speed centrifugation  and  the  supernatant  fluid 
collected. The 140S-b particles in the  supernatant fluid were  then  isolated  by 
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A  light-scattering  band characteristic  of FMDV  was formed in  the  CsC1 layer 
and was collected and dialyzed free of CsC1 in the usual manner. 
The precipitin  reactions  obtained  with  the  140S-b  preparation,  and  the  re- 
activity of the anti-140S-ab  serum  (7-DPI serum absorbed with  150 #g of 140 
S-Hi-pass virus)  are shown in Figs. 6 and 7 in conjunction  with  other samples. 
FIG. 7. Precipitin  reactions  of guinea  pig  (a)  7-day postinfection  serum  (undiluted);  (b) 
7-day posfinfection serum absorbed with 150 #g of 140S-Hi-pass virus/ml serum  (undiluted) ; 
(c)  anti-140S  serum  (diluted  ]/~); and  (d)  hyperimmune serum  (diluted  1/~) with  FMDV, 
A-119, preparations.  (1)  140S-Hi-pass virus;  (2)  140S-Lg.pl. virus;  (3)  140S-Sm.pl. virus; 
(4)  140S-b virus;  and  (5)  140S-Lo-pass virus.  All virus preparations were at approximately 
500/zg/ml. 
The  140S-b  preparation  reacted  with  7-DPI  serum  and  formed  a  band  that 
coalesced with the  140S-b band of the  140S-Hi-pass preparation  (Fig.  6  a).  It 
did  not  react  with the anti-140S-ab  serum  as indicated  previously  (Fig.  7  b). 
Tested  against anti-140S  sera (Fig.  6  b)  and hyperimmune sera (Fig.  6 c),  the 
140S-b preparation  gave a  single band  that coalesced with  the single band  ob- 
tained with  the  140S-Hi-pass preparation  and  there was no indication  of spur- 
ring. This again illustrated  the marked difference in reactivity of antibodies in 
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Reactivity of Alternate Sources of FMDV, A-119.--The experiments described 
up to this point involved only 140S-Hi-pass  virus. We examined the reactivity 
of low passage tissue culture virus (140S-Lo-pass),  a guinea pig vesicular fluid 
source of virus (140S-GP),  140S-Hi-pass  virus that had been adapted to guinea 
pigs (140S-TC-GP), and the large and small plaque variants (140S-Lg.pl.,  and 
140S-Sm.pl.,  respectively) of virus derived from the 140S-Hi-pass  virus. The 
large and small plaque variants were of particular interest as  it was demon- 
strated by neutralization studies that the two isolates were antigenically differ- 
ent, although they were related.  4 
The  initial experiments  compared  the reactivity of  140S-Hi-pass,  140S-b, 
140S-Lo-pass,  and the guinea pig viruses when tested against 7-DPI (Fig. 6 a), 
anti-140S (Fig. 6 b), and hyperimrnune (Fig. 6 c) sera. The 7-DPI serum gave 
the usual two bands with the 140S-Hi-pass  virus, and the 140S-b antigen coa- 
lesced with the 140S-b band of the 140S-Hi-pass  virus preparation; however, the 
140S-Lo-pass,  140S-GP,  and 140S-TC-GP preparations gave only a single band 
that coalesced with the 140S-ab band of the  140S-Hi-pass  preparation.  Thus, 
the low-passage tissue culture virus  and the guinea pig  adapted viruses ap- 
peared  to be devoid of 140S-b particles,  or at least these particles were not 
demonstrable by this assay. It should be noted that the precipitin band formed 
by 140S-b particles neither crossed nor fused with the 140S-ab band. The pos- 
sible significance of this reaction will be presented in the Discussion. 
As in the case of the enzyme-treated virus preparations, the anti-140S  (Fig. 
6 b)  and hyperimmune (Fig. 6 c)  sera gave single coalescing precipitin bands 
with the different antigen preparations and provided no evidence of antigenic 
differences between the various preparations. 
The  140S-Lg.pl.  and  140S-Sm.pl.  preparations  were  next examined along 
with other virus preparations (Fig. 7).  The 140S-Lg.pl.  virus consisted of only 
demonstrable 140S-ab particles while the 140S-Sm.pl.  preparation appeared to 
correspond with 140S-b particles. It may be noted, however, that the 140S-SIn. 
pl. band did not coalesce  precisely with the 140S-b band of the 140S-Hi-pass 
preparation. This indicated that the 140S-b preparation was different than the 
140S-Sm.pl.  virus;  therefore, a  plaque assay was performed with the  140S-b 
preparation on calf kidney cell cultures, and plaques having a diameter of 4-6 
mm were evident at 48 hr. Bottles at the end of the virus dilution series con- 
tained well-isolated plaques, six of which were picked and then passaged twice 
in calf kidney cell cultures. Moderate volumes of each of the six plaque isolates 
were grown, concentrated with (NH4)2SO4 and checked for antigen activity. 
All six  produced a  precipitin band  that coalesced precisely with the  140S-b 
preparation. One of these plaque isolates came from a bottle in which only a 
single plaque occurred and its was selected for further virus production. Virus 
isolated from this plaque was grown in BHK-21  culture and purified as de- 
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scribed previously. Agar gel analysis demonstrated that this 140S-b preparation 
coalesced with the 140S-b band of the 140S-Hi-pass preparation and with the 
original  140S-b preparation, but produced a  spur with the 140S-Sm.pl.  virus. 
The failure to obtain a spur with the plaque isolated 140S-b partides and the 
140S-b component of the 140S-Hi-pass virus would suggest that the 140S-Sm.ph 
component was a  minor  constituent  of  140S-Hi-pass  preparations  and  had 
relatively little influence  on the precipitin reactions obtained with the latter 
samples. Again, the anti-140S and hyperimmune sera were unable to distinguish 
between the different antigenic variants of FMDV, A-119  (Figs.  7 c and 7 d). 
DISCUSSION 
The findings presented here raise two major questions: (a) what is the signifi- 
cance  and  nature  of  the  antigenicaUy  different virus partides  occurring  in 
various preparations of what must be presumed to be a single serological type 
and strain of FMDV; and (b) why can 7-DPI serum distinguish between these 
antigenic variants while hyperlmmune and anti-140S sera are unable to do so? 
This discussion  will be concerned only with the first question. However, some 
brief comment concerning  the nature of the antibody occurring in the different 
sera should be made. 
Density  gradient  ultracentrifugation  and  immunoelectrophoresis  analysis 
(Fig.  2) of the 7-DPI serum demonstrated that the antibodies responsible for 
the double bands formed with 140S-Hi-pass  virus were both of the 19S class. 
Thus,  the double banding observed could not be attributed  to  two different 
physical-chemical  classes  of  antibodies  having  different  specificities.  These 
studies also demonstrated that  the antibodies occurring in the hyperimmune 
and anti-140S  sera were of the low s rate class, and were of ~/~- and ~/1-globulin 
mobility, i.e.,  7S~ and 7S~'a. One could assume, therefore, that the differing 
reactivities observed with these sera were due to differences in the specificity of 
19S and 7S antibodies. 
In an attempt to explain the precipitin patterns obtained with 7-DPI serum 
during this study, the interpretations developed by Ouchterlony (22, 23) were 
used. It should be recognized, however, that numerous assumptions have been 
made and,  at best,  the following  explanation  is merely meant  to provide a 
hypothesis for subsequent testing.  Fig. 8 provides a  composite diagrammatic 
representation of the reactions obtained with 7-DPI serum tested against 140S- 
Hi-pass virus, 140S-b virus, and 140S-Lo-pass virus. The various reactants may 
be tentatively characterized as follows: 
(a)  7-DPI serum contains at least two different antibodies having distinct 
specificities, i.e., anti-a-determlnant  (A) and anti-b-determlnant  (B) where A 
is at higher concentration than B. 
(b) 140S-Hi-pass virus contains at least three different antigenic variants of 
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another only b-determinants (140S-b)  and  the third a  b-related determinant 
(140S-Sm.pl.). The 140S-ab particles are the major constituent in 140S-Lg.pl., 
140S-Lo-pass,  140S-GP  and  140S-TC-GP preparations,  whereas  140S-b  par- 
ticles appear  to be the major component in  140S-Hi-pass preparations.  The 
140S-Sm.pl.  virus  is  devoid of the  a-determinant sites  and  is  antigenically 
related to 140S-b particles. 
A factor that aided in this interpretation of these reactions was the failure of 
the 140S-b band to either cross or fuse with the 140S-ab band (Figs. 6 and 7). 
This would be equivalent to reaction Type IV described by Ouchterlony which 
is attributed to two antigenic particles having a common antigenic determinant 
(b-determinant), but one of them having an additional  distinct one (a-deter- 
140S Lo Pass  140S Hi Pass 
Aa~Aab 
FIG. 8. Diagrammatic representation of precipifin reactions obtained with 7-day postinfec- 
tion guinea pig serum (center well) and FMDV, A-119, preparations: 140S-Hi-pass, 140S-Lo- 
pass, and  140S-b. Letters  a  and  b  indicate unrelated antigenic sites and ab inside ellipse 
indicates an antigenic particle on which both determinants occur.  A and B are the correspond- 
ing antibodies  to these antigenic determinants. Reactants underlined are at a relatively higher 
concentration. 
minant)  (23).  It is for this reason the viruses have been termed 140S-ab and 
140S-b particles. 
In Fig. 8, the component assumed to be in highest concentration in a given 
reservoir is  underlined;  however,  quantitative  assays  for  the  individual  re- 
actants have not been developed. The importance of relative concentration of 
reactants has been stressed by Ouchterlony (23)  and may be appreciated by 
considering Fig.  8.  If, for example,  140S-Hi-pass preparations were predomi- 
nantly mulfideterminant ab-type particles,  the Aab band would establish an 
immune barrier that B could not penetrate, and the only possibility of obtain- 
ing a second band would be that b-determlnant particles were in sufficient con- 
centrafion to form a Bb band on the serum well side of the Aab band. Consider- 
ing the relatively large size of virus particles and their resultant slow diffusion 
rate, it is likely that the faster diffusing B antibody would reach the Aab band 
area before the  140S-b  particles,  thus eliminating the possibility of Bb band ~r. M. cow~  347 
formation. This situation may exist with 140S-Lo-pass  virus and suggests why 
it is difficult to demonstrate 140S-b in such preparations. It is for this reason 
that the 140S-b component of the 140S-Lo-pass  virus was assigned a question 
mark in Fig. 8. 
With this interpretation of the results, the antigenic structure of "normal" or 
wild virus is probably one where both a- and b-determinants occur on the same 
particle. This is indicated by the fact that the guinea pig virus was of the 140S- 
ab type, and also that 140S-Hi-pass  virus reverted to a predominant 140S-ab 
type upon passage in guinea pigs. Apparently, 140S-b particles developed to 
predominance upon high tissue culture passage but,  unfortunately, samples 
were not available of the various passage levels. Therefore, it was not possible to 
determine if the apparent shift from 140S-ab dominance to 140S-b dominance 
was a sudden or gradual process. 
The interpretation of precipitin patterns obtained with 7-DPI serum does 
not consider the observations made with trypsin- and chymotrypsin-treated 
virus preparations nor with the 140S-Sm.pl. virus. Obviously, the interpretation 
is a gross simplification of the actual situation. Whether the antigenic differences 
observed with enzyme-treated virus are attributable to the exposure of masked 
antigenic determinants or  to  conformational changes occurring on the virus 
surface is not known. However, it is of interest that the 7-DPI serum was able to 
reveal these alterations indicating that the infected animals had been exposed 
and responded to these antigenic determinants during the course of the in- 
fection. 
The finding that anti-a antibody was unable to neutralize the virus suggests 
that virus particles having the relatively simple structure and chemical com- 
position of FMDV may contain both  critical and noncritical neutralization 
sites. The occurrence of the a-determinants on "animal" virus, compared to 
highly tissue culture-adapted virus provides ample grounds for speculation as 
to  its  possible  significance on  the  pathogenicity of  FMDV;  however,  such 
speculation would be premature. Still this demonstration of an apparently non- 
critical antigenic determinant site in FMDV could reasonably be of concern in 
resolving problems related to the nonneutralizable fraction occurring in virus- 
antibody mixtures. The possibility that  antibody combined to  a  noncritical 
antigenic site could sterically hinder the attachment of antibody to the critical 
site might be considered in view of analogous situations reported for various 
enzyme-anti-enzyme systems (24). 
A  point of interest will be the determination of the relative content of b- 
determinant sites on 140S-ab  and 140S-b particles. If, as the results suggest, 
neutralization occurs through the b-determinant site,  this site would also be 
expected  to be responsible for the stimulation of neutralizing antibodies. If 
differences in b-determinant content were found with the two types of particles, 
a  concomitant difference in immunizing ability might be  anticipated. Thus, 348  ANTIGENIC  VARIANTS  OP  FOOT-AND-MOUTH  DISEASE  VIRUS 
for purposes of standardizing  vaccines by in vitro assays, it may not suffice 
to  calibrate  to  equivalent virus mass concentrations  as reported by Graves 
et al.  (25),  but it would probably be necessary to calibrate to equivalent b- 
determinant  content.  Experiments  are  in  progress  to  evaluate  these  possi- 
bilities. 
Foot-and-mouth  disease virus is  a  relatively simple  virus  consisting  of a 
single-stranded  RNA core and  a  protein coat.  The  140S-Hi-pass  virus used 
in these studies has been examined  rigorously and reported to be homogeneous 
by chemical,  ultracentrifugal,  and electrophoretic tests (8,  10,  11)  and to be 
composed of repeating units of a single polypeptide (26).  Similarly,  immtmo- 
diffusion  assays utilizing  antisera containing antibodies of the 7S class would 
also  indicate  homogeneity  (14).  However, immunological  studies  suggested 
density heterogeneity (13), and the studies of Martinsen  4 demonstrated plaque 
heterogeneity, which was related to antigenic differences between the plaque 
isolates.  The  present  studies  dramatically  demonstrated  antigenic  hetero- 
geneity and indicate that antibodies of the 19S class are far superior to anti- 
bodies of the 7S class in their discriminating  capabilities. 
Future  studies  on virus will  necessitate  detailed  immunological  and  bio- 
logical  investigations  to relate antigenic  structure  of these variants  to  their 
pathogenicity and immunogenicity.  Similarly,  physical and  chemical  studies 
will be required to determine if the antigenic differences  are attributable  to 
conformational  differences  of  the  protein  coat  at  a  tertiary  or  quaternary 
structural level, to amino acid content or sequence differences or both, or to the 
variable occurrence of additional protein constituent(s). 
S~RY 
Three  antigenic  variants  of foot-and-mouth  disease virus,  type A,  strain 
119, were  demonstrated  in  Ouchterlony  analyses  utilizing  serum  collected 
from guinea pigs 7 days postiafection (DPI). Such antisera contain antibodies 
of the 19S class. Guinea pig antisera that contained antibodies of the 7S class 
were unable to distinguish between the antigenic  variants. Similarly,  19S anti- 
body was able to demonstrate  antigenic  differences  in  trypsin-  and  chymo- 
trypsin-treated  viruses  that  were  not  detected  by  7S  antibody-containing 
antisera. 
One of the antigenic variants  of virus is apparently  the wild  type and is 
tentatively considered to have  two antigenic  determinant  groupings  termed 
the a- and b-sites (140S-ab). The 140S-ab variant was the sole or predominant 
antigenic type produced in guinea pigs and in large plaque-forming- and tissue 
culture-low passage sources of the virus. Another antigenic variant appears to 
possess only the b-site (140S-b) and was the major constituent in tissue culture- 
high passage virus preparations. The third variant, a small plaque former, was 
also devoid of the a-site and contains an antigenic  determinant that is related a.  M.  cowAl~  349 
to,  but  not  identical  with,  the  b-site.  This  variant  appears  to  be  a  minor 
constituent  of tissue culture-high passage virus. 
7-DPI  serum  could  be  absorbed  with  a  suitable  concentration  of  tissue 
culture-high passage virus to remove antibody reactive with the b-determinant 
site.  This  absorbed  serum  still  precipitated  140S-ab  virus by virtue  of  still 
containing  antibody  reactive  with  the  a-determinant  site;  however,  the 
neutralizing  activity was eliminated.  This suggests that  the b-site is critical 
with respect to neutralization  while the a-site is noncritical. 
I wish to thank Mr. Jay Card for his excellent technical assistance, and Dr. John Graves, 
Mrs. Ethel Appelt, and Mr. Freddie Lawson for growing the various tissue culture sources of 
virus used in these studies. 
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